Literature DB >> 22158356

Re-evaluating PARP1 inhibitor in cancer.

Alexei Tulin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22158356     DOI： 10.1038/nbt.2058

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  22 in total

1.  NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1.

Authors:  Mi Young Kim; Steven Mauro; Nicolas Gévry; John T Lis; W Lee Kraus
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

2.  Drosophila histone H2A variant (H2Av) controls poly(ADP-ribose) polymerase 1 (PARP1) activation in chromatin.

Authors:  Elena Kotova; Niraj Lodhi; Michael Jarnik; Aaron D Pinnola; Yingbiao Ji; Alexei V Tulin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

3.  Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice.

Authors:  F J Oliver; J Ménissier-de Murcia; C Nacci; P Decker; R Andriantsitohaina; S Muller; G de la Rubia; J C Stoclet; G de Murcia
Journal:  EMBO J       Date:  1999-08-16       Impact factor: 11.598

4.  Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells.

Authors:  Ponnari Gottipati; Barbara Vischioni; Niklas Schultz; Joyce Solomons; Helen E Bryant; Tatjana Djureinovic; Natalia Issaeva; Kate Sleeth; Ricky A Sharma; Thomas Helleday
Journal:  Cancer Res       Date:  2010-06-15       Impact factor: 12.701

5.  Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes.

Authors:  Raga Krishnakumar; Matthew J Gamble; Kristine M Frizzell; Jhoanna G Berrocal; Miltiadis Kininis; W Lee Kraus
Journal:  Science       Date:  2008-02-08       Impact factor: 47.728

6.  Drosophila poly(ADP-ribose) glycohydrolase mediates chromatin structure and SIR2-dependent silencing.

Authors:  Alexei Tulin; Natalia M Naumova; Ammini K Menon; Allan C Spradling
Journal:  Genetics       Date:  2005-10-11       Impact factor: 4.562

7.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.

Authors:  Helen E Bryant; Niklas Schultz; Huw D Thomas; Kayan M Parker; Dan Flower; Elena Lopez; Suzanne Kyle; Mark Meuth; Nicola J Curtin; Thomas Helleday
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

8.  Correlation between endogenous nucleosomal hyper(ADP-ribosyl)ation of histone H1 and the induction of chromatin relaxation.

Authors:  R J Aubin; A Fréchette; G de Murcia; P Mandel; A Lord; G Grondin; G G Poirier
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  The Drosophila heterochromatic gene encoding poly(ADP-ribose) polymerase (PARP) is required to modulate chromatin structure during development.

Authors:  Alexei Tulin; Dianne Stewart; Allan C Spradling
Journal:  Genes Dev       Date:  2002-08-15       Impact factor: 11.361

10.  Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci.

Authors:  Alexei Tulin; Allan Spradling
Journal:  Science       Date:  2003-01-24       Impact factor: 47.728
View more
  8 in total

1.  Non-NAD-like PARP-1 inhibitors in prostate cancer treatment.

Authors:  Yaroslava Karpova; Chao Wu; Ali Divan; Mark E McDonnell; Elizabeth Hewlett; Peter Makhov; John Gordon; Min Ye; Allen B Reitz; Wayne E Childers; Tomasz Skorski; Vladimir Kolenko; Alexei V Tulin
Journal:  Biochem Pharmacol       Date:  2019-03-15       Impact factor: 5.858

2.  Site-specific characterization of the Asp- and Glu-ADP-ribosylated proteome.

Authors:  Yajie Zhang; Jianqi Wang; Ming Ding; Yonghao Yu
Journal:  Nat Methods       Date:  2013-08-18       Impact factor: 28.547

3.  Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets.

Authors:  Claire E Knezevic; Gabriela Wright; Lily L Remsing Rix; Woosuk Kim; Brent M Kuenzi; Yunting Luo; January M Watters; John M Koomen; Eric B Haura; Alvaro N Monteiro; Caius Radu; Harshani R Lawrence; Uwe Rix
Journal:  Cell Chem Biol       Date:  2016-11-17       Impact factor: 8.116

Review 4.  Histone-dependent PARP-1 inhibitors: A novel therapeutic modality for the treatment of prostate and renal cancers.

Authors:  Peter Makhov; Robert G Uzzo; Alexei V Tulin; Vladimir M Kolenko
Journal:  Urol Oncol       Date:  2020-05-08       Impact factor: 2.954

5.  Single cell resolution in vivo imaging of DNA damage following PARP inhibition.

Authors:  Katherine S Yang; Rainer H Kohler; Matthieu Landon; Randy Giedt; Ralph Weissleder
Journal:  Sci Rep       Date:  2015-05-18       Impact factor: 4.379

6.  Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivo.

Authors:  Colin Thomas; Yingbiao Ji; Niraj Lodhi; Elena Kotova; Aaron Dan Pinnola; Konstantin Golovine; Peter Makhov; Kate Pechenkina; Vladimir Kolenko; Alexei V Tulin
Journal:  EBioMedicine       Date:  2016-10-04       Impact factor: 8.143

7.  Comprehensive Analysis of Copy Number Variations in Kidney Cancer by Single-Cell Exome Sequencing.

Authors:  Wenyang Zhou; Fan Yang; Zhaochun Xu; Meng Luo; Pingping Wang; Yu Guo; Huan Nie; Lifen Yao; Qinghua Jiang
Journal:  Front Genet       Date:  2020-01-23       Impact factor: 4.599

Review 8.  Post-transcriptional regulation by poly(ADP-ribosyl)ation of the RNA-binding proteins.

Authors:  Yingbiao Ji; Alexei V Tulin
Journal:  Int J Mol Sci       Date:  2013-08-05       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.